Single Cell Spatial Analysis in Tissue

组织中的单细胞空间分析

• 批准号: 10260458
• 负责人: Jared Kyle Burks
• 金额: $ 25.84万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-09 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10260458
• 关键词: Biological Assay; Biological Sciences; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cell Communication; Cell Separation; Cells; Collaborations; Complex; Comprehensive Cancer Center; Consultations; Core Facility; Cytometry; Education; Ensure; Equipment; Experimental Designs; Faculty; Flow Cytometry; Growth; Hour; Image; Immune; Industry; Methodology; Microscope; Modeling; Process; Proteomics; Publications; Reporting; Research; Research Personnel; Services; Source; Standardization; Suspensions; Technical Expertise; Technology; Testing; Tissues; Training; University of Texas M D Anderson Cancer Center; anticancer research; cancer genomics; cellular imaging; flexibility; imaging facilities; imaging system; instrumentation; liquid crystal polymer; member; neoplastic cell; new technology; novel; programs; single cell technology; stem; success; tool

Project Summary/Abstract Flow Cytometry, Mass Cytometry, Cell Sorting, and Imaging are essential tools for a wide range of methodologies aimed at understanding complex single cell proteomic and genomic cancer research. The instrumentation involved is large, complex, and can be difficult to maintain and operate. As such, a targeted core facility is critical for a Comprehensive Cancer Center such as MD Anderson. The FCCIF, est. 1982, provides these services. Since the last CCSG renewal (2012) 404 cancer center members from all 16 cancer center programs have used the facility and produced 604 publications. Many of the hot topics in cancer biology currently stem from immune cell interaction with the tumor cell; immunephenotyping is an in demand field of research that requiring a unique high plex assay. This requires a specialized imaging or cytometry approach and the FCCIF has specifically acquired two different platforms because of their diversity and flexibility. These platforms are the Vectra Multispectral imaging system and the CyTOF (suspension and imaging) Mass Cytometers. The FCCIF provides a common source of state-of-the-art expertise and technical skills to support the varied research efforts of MD Anderson investigators. The FCCIF provides a comprehensive service to all of the institutional investigators regardless of prior expertise. Dr. Jared K. Burks (author of this R50, co-Director of the FCCIF-NC) provides critical services including: 1) education, 2) consultation on needed technological approach, 3) training on equipment use, analytics, and proper experimental design. I identify and acquire novel technologies for use by MDACC investigators and I provide support in a manner to ensure success and mitigate pitfalls. I am expected to develop new strategies and technologies to meet the research needs of our faculty. A few examples of what I have currently been working on is the Vectra Polaris Multispectral Microscope, Helios and Hyperion Suspension and Imaging CyTOFs. The Polaris has operated on average 13.5 hours per day for the last year. The CyTOFs are reporting 5090% growth since the last CCSG renewal. These results stem from mitigating the pitfalls, making the technologies approachable and affordable, and supporting the researchers throughout the process all the way to publication. Collaborations, both academic and industry, have resulted to develop or test novel applications. The models we have created to support these technologies have and will continue to be shared with others operating the technologies. We are highly involved with both developing and standardizing new technologies for use at MD Anderson and with our facilities and researchers implementing them worldwide.

项目总结/文摘